GLP-1 medications , or glucagon-like peptide-1 compounds, represent a substantial innovation in how we treat type 2 diabetes . These new therapies help imitating the body’s inherent GLP-1 process, https://imogeneceo533049.aboutyoublog.com/54370721/glp-1-a-significant-breakthrough-in-glucose-treatment